International trade · 27/05/1998Updated: 10/17/2026 · 1 min read
U.S. Trade Representative Terminates Investigation into India's Patent Protection Practices
Summary
The U.S. Trade Representative has determined that India's patent protection practices for pharmaceuticals and agricultural chemicals violate the TRIPS Agreement, but has decided not to take action under the Trade Act at this time, citing India's commitment to comply with WTO obligations and amend its law by April 19, 1999.
Original source language: Federal Register — Trade RepresentativeOpen original release →